MOSCOW, August 4 (RIA Novosti) - Several domestic and international food producers, operating in the US, have been sent warning letters by the US Food and Drug Administration, Food Safety News reports.
The FDA stated that egg-producer Corporacion Avicola Morovis did not meet necessary requirements. The violations by the Puerto Rican egg producer included a failure to produce a written Salmonella Prevention plan that includes measures to prevent cross contamination between poultry houses. Upon inspection, the FDA found wild birds, nesting within poultry houses, and cattle in manure pits and surrounding areas, according to the warning letter.
Franzese SPA, an Italian canned-food processor also violated FDA requirements, related to emergency permit controls and thermally processed low-acid foods.
Five seafood processors also received warnings for violations of seafood Hazard Analysis and Critical Control Point (HACCP) regulations.
US firms, given letters for violations, include K-Fat and SSE Manufacturing. The warning letter to K-Fat said its vacuum-packed frozen anchovy product were prepared, packed and handled under unsanitary conditions, which can be potentially dangerous to health. The Texas-based SSE Manufacturing warning letter found issues with their shrimp, which upon inspection contained sulfating agents found harmful to some people.
Sushi Den Japan, India’s Accelerated Freeze Drying, and Ecuador’s Good Fish all failed to possess complete HACCP plans covering all seafood processed at their facilities.
Hoke Farms in Pennsylvania and Double D Dairy in Michigan received letters from the FDA addressing their misuse of animal drugs on their cattle. Bliss Dairy a Utah-based facility received a warning regarding the sale of a dairy cow intended for slaughter. Excessive levels of the drugs Flunixin and Desfuroylceftiofur were found in the cow after tissue sampling.
All recipients of the warnings have 15 working days to respond with an outline of specific steps taken to comply with food safety laws and regulations and solve the problems reported by the FDA.
